Story perspectives

UK-US Deal Threatens Drug Prices, Experts Warn

12/2/2025

32 4

Summary

Story summary

Australian Health Minister Mark Butler warned the UK-US deal would raise UK drug prices by 25%.
Experts warned the deal could undermine the National Health Service's funding for treatments and staff.
Butler highlighted the Pharmaceutical Benefits Scheme as essential to maintaining affordable access to medicines.
Experts including Prof. Libby Roughead and Dr. Barbara Mintzes warned the agreement could undermine cost-effectiveness assessments and set a precedent pressuring other countries, including Australia.

1 of 1

Story summary

Australian Health Minister Mark Butler warned the UK-US deal would raise UK drug prices by 25%.
Experts warned the deal could undermine the National Health Service's funding for treatments and staff.
Butler highlighted the Pharmaceutical Benefits Scheme as essential to maintaining affordable access to medicines.
Experts including Prof. Libby Roughead and Dr. Barbara Mintzes warned the agreement could undermine cost-effectiveness assessments and set a precedent pressuring other countries, including Australia.